As 3D printing drugs in rural hospitals becomes a reality, what are the opportunities and threats for AstraZeneca?

In rural hospitals, critical drugs are often not in stock. Desperate patients and their families are further pushed into prolonged suffering. Feeling they have nothing to lose, some resort to DIY solutions.

As additive manufacturing is applied to drug production at patients’ closest point of sale, we can imagine a world where rural patients purchase out-of-stock drugs within a few hours of visiting a local hospital. What if the hospital had a 3D printer? What if CAD files from global pharmaceutical companies like AstraZeneca were available?

Creating a “Factory of the Future”

How machine learning can improve inefficiencies and deliver cost-savings at the factory level in the manufacturing industry.

Company Brief: Indorama Ventures (IVL) is a petrochemical company, operating in 29 countries across five continents. Their operations are mainly in the manufacturing of polyethylene terephthalate (PET), a polyester resin used for the production of fibers and liquid and food containers.